Tiziana Life Sciences PLC Directorate Change

Rhea-AI Summary

Tiziana Life Sciences plc (NASDAQ: TLSA) has announced that Gregor MacRae is stepping down as a director effective immediately. Gabriele Cerrone, the Chairman, expressed gratitude for MacRae's contributions and indicated ongoing efforts to recruit a new non-executive director with significant NASDAQ audit committee experience. The company is hopeful for a formal announcement regarding this new appointment soon. This announcement contains inside information as defined by EU Regulation 596/2014.

Positive

• Recruitment of a new non-executive director could enhance the board's expertise.
• Focus on experience in NASDAQ audit committee may strengthen governance.

Negative

• Immediate departure of a board member could signal instability at the leadership level.

LONDON and NEW YORK, June 18, 2020 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (NASDAQ: TLSA / AIM: TILS) ("Tiziana" or the "Company"), the U.S. and U.K. biotechnology company that focuses on the discovery and development of novel molecules to treat human disease in oncology and immunology, announces Gregor MacRae is standing down as a director of the Company with immediate effect.

Gabriele Cerrone, Chairman of Tiziana, said "I thank Gregor for his contribution to the Board and the Company and wish him well in his other interests. We are currently in the process of recruiting a new, seasoned non-executive director with extensive NASDAQ audit committee experience and hope to make a formal announcement shortly".

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Contacts:

For further enquiries: 

100%; border-collapse:collapse !important;">

United Kingdom:
Tiziana Life Sciences plc Gabriele Cerrone, Chairman and founder	+44 (0)20 7493 2379
Cairn Financial Advisers LLP (Nominated adviser) Liam Murray / Jo Turner	+44 (0)20 7213 0880
Optiva Securities Limited (Broker) Robert Emmet	+ 44 (0)20 3981 4173

United States:
Investors -
CORE IR
(516) 222-2560
ir@coreir.com
Media
Jules Abraham
CORE IR
(917) 885-7378
julesa@coreir.com

For more information go to http://www.tizianalifesciences.com

FAQ

Why did Gregor MacRae leave Tiziana Life Sciences?

Gregor MacRae stepped down as a director of Tiziana Life Sciences with immediate effect for personal reasons.

What is the stock symbol for Tiziana Life Sciences?

The stock symbol for Tiziana Life Sciences is TLSA.

What is Tiziana Life Sciences focused on?

Tiziana Life Sciences focuses on discovering and developing novel molecules for treating human diseases in oncology and immunology.

Is Tiziana Life Sciences looking for a new director?

Yes, Tiziana Life Sciences is in the process of recruiting a new non-executive director with extensive NASDAQ audit committee experience.